Dealert Deals Culsana

Holland Capital Culsana

Buyout Other Advanced Medical Equipment & Technology (NEC) Other / Unspecified
Deal summary

Information on the target

Holland Capital, a prominent private equity firm, has recently expanded its operations by becoming a full member of The German Private Equity and Venture Capital Association (BVK) as of September 2022. This membership signifies Holland Capital's commitment to the German private equity market, enhancing its strategic positioning within the healthcare and technology sectors. The firm has a rich history of over 40 years in private equity investment, focusing on small and medium-sized enterprises (SMEs) and fostering growth in innovative markets.

With a dedicated office in Düsseldorf, Holland Capital aims to collaborate with German entrepreneurs, investors, and advisors to identify and capitalize on investment opportunities in the region. The firm has successfully invested in more than 150 SMEs, establishing a reputation for responsible and effective investment strategies that prioritize sustainable growth.

Industry overview in the target’s specific country

The Advanced Medical Equipment & Technology (NEC) industry in Germany is characterized by its robust growth and innovation, driven by a strong healthcare system and a commitment to technological advancement. Germany is one of the largest healthcare markets in Europe, with a significant emphasis on research and development. The country is home to numerous leading medical technology companies that are at the forefront of developing cutting-edge medical devices and equipment.

In recent years, the German government has increased its investment in healthcare infrastructure, which has further stimulated growth in the Advanced Medical Equipment & Technology sector. This investment is aimed at improving patient care and enhancing the efficiency of healthcare delivery systems. The integration of digital health technologies, such as telemedicine and electronic health records, is also reshaping the landscape, creating new opportunities for innovation and investment.

Moreover, the aging population in Germany is driving demand for advanced medical technologies, as healthcare providers seek to improve outcomes for elderly patients. This demographic shift is expected to continue, leading to sustained growth in the sector. Additionally, Germany's strong regulatory framework ensures high standards for medical devices, which enhances the credibility and competitiveness of its medical technology firms on a global scale.

As a result, the Advanced Medical Equipment & Technology industry in Germany presents a compelling investment landscape, characterized by a combination of strong market demand, technological innovation, an…

This is a public preview. The full deal page — disclosed financials, full description, advisers, comparable set — is available with a free account.
Create free account
View primary source ↗